Fralex announces the listing of its common shares on the NEX board of the TSX Venture Exchange

    TORONTO, April 17 /CNW/ - Fralex Therapeutics Inc. (NEX: FXI.H)
("Fralex") announces that its common shares commenced trading on the NEX board
of the TSX Venture Exchange under a new trading symbol "FXI.H", effective at
the NEX market opening today. Unable to meet the continued listing
requirements of the TSX, Fralex's common shares were delisted from the TSX at
the close of business on April 16, 2009, at the request of Fralex.

    About FRALEX:

    For more information about FRALEX, please visit

For further information:

For further information: Avi Grewal, President and Chief Executive
Officer, Fralex Therapeutics Inc., (416) 213-8118 ext. 210,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890